Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · INTELLIGENT BIO SOLUTIONS INC. (INBS)

Intelligent Bio Solutions amends bylaws on stockholder vote counting and posts investor presentation

Neutral Impact 2 of 5 shareholder Written later

Intelligent Bio Solutions adopted Second Amended and Restated Bylaws on October 12, 2026. The main change clarifies that non-director matters are decided by a majority of votes cast, excluding broker non-votes and abstentions, which now have no effect on the outcome. The company also furnished an investor presentation made available on October 13, 2026.

Key points

  • Bylaws adopted by the Board on October 12, 2026, effective on that date
  • Non-director matters decided by majority of votes cast, excluding broker non-votes; abstentions also excluded and have no impact
  • Company furnished investor presentation made available October 13, 2026, posted in the Investors section of www.ibs.inc

The filing

CompanyINTELLIGENT BIO SOLUTIONS INC. (INBS)
Form8-K, current report
Filed with the SECOct 13, 2026, 5:00 PM ET
Accession number0001493152-26-046863

Items reported: 5.03 Bylaw / Charter Amendment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.